Monitoring Response to Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI

NCT02848560 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Hyperpolarized Xenon

Sponsor

Children's Hospital Medical Center, Cincinnati

Collaborators

[object Object]